WORLD'S LARGEST MARKET RESEARCH RESOURCE — 1,519,265 REPORTS

 
 
• SEARCH FOR A REPORT

Viewing report

Search
Enter keywords, a title or a report id number below.
Advanced

• ORDER BY FAX

Order By Fax

• SELECT SITE CURRENCY

Select a currency for use throughout the site



  • Electronic (PDF) Information Icon
  • Site License Information Icon
  • Enterprisewide Information Icon
Live Chat Live Help Software for Website

Nicotine Addiction Global Clinical Trials Review, H1, 2012

GlobalData, February 2012, Pages: 84

Nicotine Addiction Global Clinical Trials Review, H1, 2012

Summary

GlobalData's clinical trial report, “Nicotine Addiction Global Clinical Trials Review, H1, 2012" provides data on the Nicotine Addiction clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Nicotine Addiction. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Nicotine Addiction. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Keywords

Nicotine Addiction Clinical Trials, Trial Designs, Subjects Recruited, Unaccomplished Trials of Nicotine Addiction , Pfizer, AstraZeneca, Novartis, GlaxoSmithKline, Sanofi, Eli Lilly and Company, Johnson & Johnson, Merck & Co., Inc, Bristol-Myers Squibb Company, Abbott Laboratories, Hoffmann-La Roche Ltd., Celgene Corporation, Daiichi Sankyo Company, Ltd., Bayer AG, Eisai Inc., GE Healthcare, Biogen Idec Inc., Copharos Inc., Wyeth Pharmaceuticals Inc., National Cancer Center, The University of Texas, M.D. Andersons, Vanderbilt Medical Center, Memorial Sloan Kettering Cancer Center, Cancer Research UK, North Central Cancer Group, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Fred Hutchinson Cancer Research Center, European Organization for Research and Treatment of Cancer, Dana-Farber Cancer Institute, The Cancer and Leukemia Group B, Columbia University, UCLA's Jonsson Comprehensive Cancer Center, Case Comprehensive Cancer Center, Mayo Clinic, Duke University, Ohio State University, National Cancer Center, University of Pennsylvania.



List of Tables
List of Figures
Introduction
Nicotine Addiction
Report Guidance
Clinical Trials by Region
Clinical Trials by Country
Top Five Countries Contributing to Clinical Trials in Asia-Pacific
Top Five Countries Contributing to Clinical Trials in Europe
Top Countries Contributing to Clinical Trials in North America
Top Countries Contributing to Clinical Trials in Middle East and Africa
Clinical Trials by BRIC Nations
Clinical Trials by G7 Nations
Clinical Trials in G7 Nations by Trial Status
Clinical Trials by E7 Nations
Clinical Trials in E7 Nations by Trial Status
Clinical Trials by Phase
In Progress Trials by Phase
Clinical Trials by Trial Status
Unaccomplished Trials of Nicotine Addiction
Subjects Recruited Over a Period of Time
Prominent Sponsors
Top Companies Participating in Nicotine Addiction Therapeutics Clinical Trials
Prominent Drug Comparison
Clinical Trial Profiles
Clinical Trial Overview of Top Companies
Johnson & Johnson
Clinical Trial Overview of Johnson & Johnson
Pfizer Inc.
Clinical Trial Overview of Pfizer Inc.
Rock Creek Pharmaceuticals INC
Clinical Trial Overview of Rock Creek Pharmaceuticals INC
Star Scientific, Inc.
Clinical Trial Overview of Star Scientific, Inc.
Deschutes Research, Inc.
Clinical Trial Overview of Deschutes Research, Inc.
Freedom Health Inc.
Clinical Trial Overview of Freedom Health Inc.
RAND Corporation
Clinical Trial Overview of RAND Corporation
Niconovum AB
Clinical Trial Overview of Niconovum AB
Japan Tobacco Inc.
Clinical Trial Overview of Japan Tobacco Inc.
EnVivo Pharmaceuticals
Clinical Trial Overview of EnVivo Pharmaceuticals
Nabi Biopharmaceuticals
Clinical Trial Overview of Nabi Biopharmaceuticals
Eli Lilly and Company
Clinical Trial Overview of Eli Lilly and Company
Clinical Trial Overview of Top Universities / Institutes / Hospitals
National Institute on Drug Abuse
Clinical Trial Overview of National Institute on Drug Abuse
University of Pennsylvania
Clinical Trial Overview of University of Pennsylvania
Mayo Clinic
Clinical Trial Overview of Mayo Clinic
Centre for Addiction and Mental Health
Clinical Trial Overview of Centre for Addiction and Mental Health
Yale University
Clinical Trial Overview of Yale University
Massachusetts General Hospital
Clinical Trial Overview of Massachusetts General Hospital
Duke University
Clinical Trial Overview of Duke University
University of Wisconsin Madison
Clinical Trial Overview of University of Wisconsin Madison
Medical University of South Carolina
Clinical Trial Overview of Medical University of South Carolina
University of Minnesota
Clinical Trial Overview of University of Minnesota
Butler Hospital
Clinical Trial Overview of Butler Hospital
U.S. Department of Veterans Affairs
Clinical Trial Overview of U.S. Department of Veterans Affairs
University of California, San Francisco
Clinical Trial Overview of University of California, San Francisco
University of Medicine and Dentistry New Jersey
Clinical Trial Overview of University of Medicine and Dentistry New Jersey
Stanford University
Clinical Trial Overview of Stanford University
Hadassah Medical Organization
Clinical Trial Overview of Hadassah Medical Organization
University of Massachusetts
Clinical Trial Overview of University of Massachusetts
University of Virginia
Clinical Trial Overview of University of Virginia
University of Connecticut Health Center
Clinical Trial Overview of University of Connecticut Health Center
Queen Mary, University of London
Clinical Trial Overview of Queen Mary, University of London
Five Key Clinical Profiles
Appendix
Abbreviations
Definitions
Research Methodology
Secondary Research
About GlobalData
Contact Us
Disclaimer
Source

List of Tables
Nicotine Addiction Therapeutics Market, Global, Clinical Trials by Zone, 2012-
Nicotine Addiction Therapeutics Market, Global, Clinical Trials by Top Countries, 2012-
Nicotine Addiction Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012-
Nicotine Addiction Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2012-
Nicotine Addiction Therapeutics Clinical Trials, Europe, Top Five Countries, 2012-
Nicotine Addiction Therapeutics Clinical Trials, North America, Top Countries, 2012-
Nicotine Addiction Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2012-
Nicotine Addiction Therapeutics Clinical Trials, BRIC Countries, 2012-
Nicotine Addiction Therapeutics Clinical Trials, G7 Countries, 2012-
Nicotine Addiction Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012-
Nicotine Addiction Therapeutics Clinical Trials, E7 Countries, 2012-
Nicotine Addiction Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012-
Nicotine Addiction Therapeutics Market, Global, Clinical Trials by Phase, 2012-
Nicotine Addiction Therapeutics Market, Global, Clinical Trials In Progress by Phase 2012-
Nicotine Addiction Therapeutics Market, Global, Clinical Trials by Trial Status, 2012-
Nicotine Addiction Therapeutics Market, Global, Withdrawn Clinical Trials, 2012-
Nicotine Addiction Therapeutics Market, Global, Terminated Clinical Trials, 2012-
Nicotine Addiction Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010
Nicotine Addiction Therapeutics Clinical Trials, Global, Key Sponsors, 2012-
Nicotine Addiction Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012-
Nicotine Addiction Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012-
Nicotine Addiction Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson & Johnson, 2012-
Nicotine Addiction Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2012-
Nicotine Addiction Therapeutics Clinical Trials Market, Global, Clinical Trials by Rock Creek Pharmaceuticals INC, 2012-
Nicotine Addiction Therapeutics Clinical Trials Market, Global, Clinical Trials by Star Scientific, Inc., 2012-
Nicotine Addiction Therapeutics Clinical Trials Market, Global, Clinical Trials by Deschutes Research, Inc., 2012-
Nicotine Addiction Therapeutics Clinical Trials Market, Global, Clinical Trials by Freedom Health Inc., 2012-
Nicotine Addiction Therapeutics Clinical Trials Market, Global, Clinical Trials by RAND Corporation, 2012-
Nicotine Addiction Therapeutics Clinical Trials Market, Global, Clinical Trials by Niconovum AB, 2012-
Nicotine Addiction Therapeutics Clinical Trials Market, Global, Clinical Trials by Japan Tobacco Inc., 2012-
Nicotine Addiction Therapeutics Clinical Trials Market, Global, Clinical Trials by EnVivo Pharmaceuticals, 2012-
Nicotine Addiction Therapeutics Clinical Trials Market, Global, Clinical Trials by Nabi Biopharmaceuticals, 2012-
Nicotine Addiction Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and Company, 2012-
Nicotine Addiction Therapeutics Clinical Trials Market, Global, Clinical Trials by National Institute on Drug Abuse, 2012-
Nicotine Addiction Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Pennsylvania, 2012-
Nicotine Addiction Therapeutics Clinical Trials Market, Global, Clinical Trials by Mayo Clinic, 2012-
Nicotine Addiction Therapeutics Clinical Trials Market, Global, Clinical Trials by Centre for Addiction and Mental Health, 2012-
Nicotine Addiction Therapeutics Clinical Trials Market, Global, Clinical Trials by Yale University, 2012-
Nicotine Addiction Therapeutics Clinical Trials Market, Global, Clinical Trials by Massachusetts General Hospital, 2012-
Nicotine Addiction Therapeutics Clinical Trials Market, Global, Clinical Trials by Duke University, 2012-
Nicotine Addiction Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Wisconsin Madison, 2012-
Nicotine Addiction Therapeutics Clinical Trials Market, Global, Clinical Trials by Medical University of South Carolina, 2012-
Nicotine Addiction Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Minnesota, 2012-
Nicotine Addiction Therapeutics Clinical Trials Market, Global, Clinical Trials by Butler Hospital, 2012-
Nicotine Addiction Therapeutics Clinical Trials Market, Global, Clinical Trials by U.S. Department of Veterans Affairs, 2012-
Nicotine Addiction Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, San Francisco, 2012-
Nicotine Addiction Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Medicine and Dentistry New Jersey, 2012-
Nicotine Addiction Therapeutics Clinical Trials Market, Global, Clinical Trials by Stanford University, 2012-
Nicotine Addiction Therapeutics Clinical Trials Market, Global, Clinical Trials by Hadassah Medical Organization, 2012-
Nicotine Addiction Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Massachusetts, 2012-
Nicotine Addiction Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Virginia, 2012-
Nicotine Addiction Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Connecticut Health Center, 2012-
Nicotine Addiction Therapeutics Clinical Trials Market, Global, Clinical Trials by Queen Mary, University of London, 2012-

List of Figures
Nicotine Addiction Therapeutics Market, Global, Clinical Trials by Zone (%), 2012-
Nicotine Addiction Therapeutics Market, Global, Clinical Trials by Top Countries, 2012-
Nicotine Addiction Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012-
Nicotine Addiction Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2012-
Nicotine Addiction Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2012-
Nicotine Addiction Therapeutics Clinical Trials, North America, Top Countries (%), 2012-
Nicotine Addiction Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2012-
Nicotine Addiction Therapeutics Clinical Trials, G7 Countries (%), 2012-
Nicotine Addiction Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012-
Nicotine Addiction Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012-
Nicotine Addiction Therapeutics Market, Global, Clinical Trials by Phase (%), 2012-
Nicotine Addiction Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2012-
Nicotine Addiction Therapeutics Market, Global, Clinical Trials by Trial Status, 2012-
Nicotine Addiction Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010
Nicotine Addiction Therapeutics Clinical Trials, Global, Key Sponsors, 2012-
Nicotine Addiction Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012-
Nicotine Addiction Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012-
GlobalData Methodology

Customers who bought this item also bought